Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

China flag China · Delayed Price · Currency is CNY
15.42
+0.20 (1.31%)
Apr 29, 2026, 3:04 PM CST
-2.41%
Market Cap 10.55B
Revenue (ttm) 3.11B
Net Income (ttm) 650.37M
Shares Out 693.22M
EPS (ttm) 0.94
PE Ratio 16.25
Forward PE n/a
Dividend 0.60 (3.89%)
Ex-Dividend Date May 26, 2025
Volume 9,348,504
Average Volume 11,480,327
Open 16.41
Previous Close 15.22
Day's Range 15.17 - 16.41
52-Week Range 14.81 - 21.07
Beta 0.29
RSI 45.41
Earnings Date Apr 27, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,125
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300181
Full Company Profile

Financial Performance

In 2025, SHE:300181's revenue was 3.04 billion, an increase of 17.96% compared to the previous year's 2.58 billion. Earnings were 631.93 million, an increase of 24.45%.

Financial Statements

News

There is no news available yet.